Irinotecan

Form: Injection/Infusion Solution

Strength: 100 mg/5 mL, 300 mg/15 mL

Reference Brands: Camptosar® (US & EU)

Category: Oncology Cancer Care

Irinotecan is an essential chemotherapy drug used in the treatment of various cancers, including colorectal, ovarian, and lung cancer. As a topoisomerase I inhibitor, it blocks DNA replication in cancer cells, preventing tumor growth. Available in intravenous (IV) solution forms, it is commonly provided in 100 mg/5 mL and 300 mg/15 mL strengths. Marketed under the brand Camptosar® by Pfizer, as well as in generic versions such as Irinotecan Accord and Irinotecan Mylan, it is widely sourced by B2B pharmaceutical wholesalers across the US and EU, ensuring reliable supply, GMP compliance, and competitive pricing for oncology centers.